Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 12/20 | 0.57 |
| ▸ | PTGER2 | P43116 | 7/20 | 0.57 |
| ▸ | PTGER3 | P43115 | 5/20 | 0.57 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.57 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.57 |
| ▸ | PTGER4 | P35408 | 6/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.48 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 1/20 | 0.48 |
| ▸ | RARG | P13631 | 1/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9760513 | 0.90 | PTGIR (0.47) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL31055788 | 0.89 | PTGIR (0.62) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL4448944 | 0.89 | PTGIR (0.62) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL20815456 | 0.89 | PTGIR (0.62) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL11459358 | 0.89 | PTGIR (0.62) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL4093287 | 0.89 | PTGIR (0.62) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL11458881 | 0.85 | PTGER2 (0.64) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL11467592 | 0.85 | PTGER2 (0.64) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL20815451 | 0.81 | PTGIR (0.63) | PTGIRPTGER2PTGER3PTGER1PTGDR | |
| SCHEMBL20815452 | 0.81 | PTGIR (0.63) | PTGIRPTGER2PTGER3PTGER1PTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163450-A1 | COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF | BAYER SCHERING PHARMA AG (DE) | 2009-06-25 | — | — | US | disclosed |
| US-5023273-A | Antiagglomerants, hypotensive agents, bronchodilators | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163450-A1 | COMBINATIONS COMPRISING A PROSTAGLANDIN AND USES THEREOF | TUBB3, TUBB, PTGES2 | PTGIR 19/4885PTGER2 14/4885PTGER3 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.